{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:53:04Z","timestamp":1789203184177,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012983","name":"Holy Spirit University of Kaslik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.heliyon.2023.e15754","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T21:52:50Z","timestamp":1682200370000},"page":"e15754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association between vitamin D deficiency and multiple sclerosis- MRI significance: A scoping review"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-6467","authenticated-orcid":false,"given":"Shorouk","family":"Hajeer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6578-872X","authenticated-orcid":false,"given":"Sanaa","family":"Nabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-belle","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayat","family":"Harati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-3890","authenticated-orcid":false,"given":"Alban","family":"Desoutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-628X","authenticated-orcid":false,"given":"Elie","family":"Al Ahmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Estephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2023.e15754_bib1","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J."},{"issue":"Suppl 6","key":"10.1016\/j.heliyon.2023.e15754_bib2","doi-asserted-by":"crossref","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","article-title":"Multiple sclerosis, a treatable disease","volume":"16","author":"Doshi","year":"2016","journal-title":"Clin. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15754_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1756285617708911","article-title":"MRI in the assessment and monitoring of multiple sclerosis: an update on best practice","volume":"10","author":"Kaunzner","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15754_bib4","first-page":"1165","article-title":"Multiple sclerosis: the role of MR imaging","volume":"27","author":"Ge","year":"2006","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.heliyon.2023.e15754_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fpsyt.2017.00047","article-title":"Vitamin-D deficiency as a potential environmental risk factor in multiple sclerosis, schizophrenia, and autism","volume":"8","author":"Ko\u010dovsk\u00e1","year":"2017","journal-title":"Front. Psychiatr."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15754_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112482","article-title":"Vitamin D and neurological diseases: an endocrine view","volume":"18","author":"Di Somma","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15754_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082245","article-title":"Vitamin D in neurological diseases: a rationale for a pathogenic impact","volume":"19","author":"Moretti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15754_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4140\/TCP.n.2010.440","article-title":"Vitamin D and Alzheimer's disease: is there a link?","volume":"25","author":"Pogge","year":"2010","journal-title":"Consult. Pharm."},{"key":"10.1016\/j.heliyon.2023.e15754_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12937-015-0063-7","article-title":"Vitamin D deficiency is associated with increased risk of Alzheimer's disease and dementia: evidence from meta-analysis","volume":"14","author":"Shen","year":"2015","journal-title":"Nutr. J."},{"key":"10.1016\/j.heliyon.2023.e15754_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphar.2014.00006","article-title":"Vitamin D supplements: a novel therapeutic approach for Alzheimer patients","volume":"5","author":"Annweiler","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15754_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JAD-131970","article-title":"Why vitamin D in Alzheimer's disease? The hypothesis","volume":"40","author":"Gezen-Ak","year":"2014","journal-title":"J. Alzheimer's Dis."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15754_bib12","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jocn.2013.01.011","article-title":"Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis","volume":"20","author":"Karam","year":"2013","journal-title":"J. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15754_bib13","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neurobiolaging.2013.11.005","article-title":"Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis","volume":"35","author":"Camu","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15754_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2023.e15754_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2016.02.008","article-title":"Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - a pilot study","volume":"293","author":"Yamout","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15754_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.17712\/nsj.2015.4.20150357","article-title":"Update in vitamin D and multiple sclerosis","volume":"20","author":"Alharbi","year":"2015","journal-title":"Neurosciences"},{"key":"10.1016\/j.heliyon.2023.e15754_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fneur.2020.00129","article-title":"Vitamin D and disease severity in multiple sclerosis-baseline data from the randomized controlled trial (EVIDIMS)","volume":"11","author":"B\u00e4cker-Koduah","year":"2020","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15754_bib18","article-title":"Cholecalciferol in relapsing-remitting MS: a randomized clinical trial (CHOLINE)","volume":"6","author":"Camu","year":"2019","journal-title":"Neurol.: Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2023.e15754_bib19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e15754_bib20","series-title":"The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-randomized Studies in Meta-Analysis","author":"Wells","year":"2000"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15754_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Contr. Clin. Trials"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15754_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.24747","article-title":"Long-term evolution of multiple sclerosis disability in the treatment era","volume":"80","author":"Cree","year":"2016","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15754_bib23","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jamaneurol.2015.2742","article-title":"Association of vitamin D levels with multiple sclerosis activity and progression in patients receiving interferon beta-1b","volume":"72","author":"Fitzgerald","year":"2015","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15754_bib24","article-title":"Inflammatory activity and vitamin D levels in an MS population treated with rituximab","volume":"5","author":"Linden","year":"2019","journal-title":"Mult. Scler J. Exp. Transl. Clin."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15754_bib25","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10072-018-3440-0","article-title":"Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod","volume":"39","author":"Ferre","year":"2018","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15754_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00415-017-8697-3","article-title":"Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials","volume":"265","author":"Hongell","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.heliyon.2023.e15754_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/acn3.91","article-title":"Molecular mechanism underlying the impact of vitamin D on disease activity of MS","volume":"1","author":"Munger","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.heliyon.2023.e15754_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105628","article-title":"Serum vitamin D level is associated with speed of processing in multiple sclerosis patients","volume":"200","author":"Darwish","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15754_bib29","first-page":"8361","article-title":"Seasonal variations of 25-OH vitamin D serum levels in Multiple Sclerosis patients with relapse using MRI","volume":"29","author":"Sistani","year":"2019","journal-title":"Eur. J. Transl. Myol."},{"key":"10.1016\/j.heliyon.2023.e15754_bib30","series-title":"Multiple Sclerosis Journal","first-page":"399","article-title":"Vitamin D and the development and evolution of permanent black holes among patients with clinically isolated syndrome","volume":"vol. 21","author":"Fitzgerald","year":"2015"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15754_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.0b013e31825fdf01","article-title":"Vitamin D and disease activity in multiple sclerosis before and during interferon-\u03b2 treatment","volume":"79","author":"L\u00f8ken-Amsrud","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15754_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1352458513494959","article-title":"Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes","volume":"20","author":"Martinelli","year":"2014","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15754_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.23591","article-title":"Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis","volume":"72","author":"Mowry","year":"2012","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15754_bib34","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1212\/NXI.0000000000000167","article-title":"Effect of vitamin D on MS activity by disease-modifying therapy class","volume":"2","author":"Rotstein","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15754_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.609","article-title":"Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland","volume":"7","author":"Wawrzyniak","year":"2017","journal-title":"Brain Behav."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15754_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1212\/WNL.0b013e3181f0734c","article-title":"Seasonal prevalence of MS disease activity","volume":"75","author":"Meier","year":"2010","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.heliyon.2023.e15754_bib37","doi-asserted-by":"crossref","first-page":"e2256","DOI":"10.1212\/WNL.0000000000006644","article-title":"Body mass index, but not vitamin D status, is associated with brain volume change in MS","volume":"91","author":"Mowry","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e15754_bib38","doi-asserted-by":"crossref","unstructured":"Ostkamp, P., Salmen, A., Pignolet, B., G\u00f6rlich, D., Andlauer, T., Schulte-Mecklenbeck, A., Gonzalez-Escamilla, G., Bucciarelli, F., Gennero, I., Breuer, J., Antony, G., Schneider-Hohendorf, T., Mykicki, N., Bayas, A., Then Bergh, F., Bittner, S., Hartung, H. P., Friese, M. A., Linker, R. A., Luessi, F., German Competence Network Multiple Sclerosis (KKNMS) and the BIONAT Network (2021). Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity. Proc. Natl. Acad. Sci. U. S. A., 118(1), e2018457118.","DOI":"10.1073\/pnas.2018457118"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15754_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp.2006.105320","article-title":"A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis","volume":"79","author":"Soilu-H\u00e4nninen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e15754_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.msard.2019.08.014","article-title":"Vitamin D and MRI measures in progressive multiple sclerosis","volume":"35","author":"Abbatemarco","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e15754_bib41","article-title":"The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis","volume":"39","author":"Lorefice","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15754_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.2010.227942","article-title":"Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients","volume":"82","author":"Weinstock-Guttman","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e15754_bib43","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/jnnp-2012-304661","article-title":"Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis","volume":"84","author":"Zivadinov","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e15754_bib44","article-title":"A randomised, double-blind, placebo-controlled trial with vitamin D3 in MS: subgroup analysis of patients with baseline disease activity despite interferon treatment","volume":"2012","author":"Aivo","year":"2012","journal-title":"Mult. Scler. Int."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15754_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon \u03b2-1b in patients with multiple sclerosis","volume":"83","author":"Soilu-H\u00e4nninen","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15754_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13760-012-0166-2","article-title":"Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial","volume":"113","author":"Derakhshandi","year":"2013","journal-title":"Acta Neurol. Belg."},{"issue":"20","key":"10.1016\/j.heliyon.2023.e15754_bib47","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1212\/WNL.0000000000008445","article-title":"Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon \u03b2-1a","volume":"93","author":"Hupperts","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15754_bib48","article-title":"High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial","volume":"6","author":"D\u00f6rr","year":"2020","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15754_bib49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/08820139.2011.573041","article-title":"Therapeutic effect of vitamin D3 in multiple sclerosis patients","volume":"40","author":"Mosayebi","year":"2011","journal-title":"Immunol. Invest."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15754_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/ene.12844","article-title":"Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection","volume":"23","author":"Mowry","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15754_bib51","article-title":"Effects of vitamin D(3) in clinically isolated syndrome and healthy control participants: a double-blind randomised controlled trial","volume":"3","author":"O'Connell","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"17","key":"10.1016\/j.heliyon.2023.e15754_bib52","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182343274","article-title":"A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis","volume":"77","author":"Stein","year":"2011","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15754_bib53","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","article-title":"A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis","volume":"76","author":"Wingerchuk","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15754_bib54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/diagnostics12010130","article-title":"Serum vitamin D as a biomarker in autoimmune, psychiatric and neurodegenerative diseases","volume":"12","author":"Bivona","year":"2022","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15754_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10528-020-10010-1","article-title":"Vitamin D and genetic susceptibility to multiple sclerosis","volume":"59","author":"Scazzone","year":"2021","journal-title":"Biochem. Genet."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023029614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023029614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:20:52Z","timestamp":1773397252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023029614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2405844023029614"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15754","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between vitamin D deficiency and multiple sclerosis- MRI significance: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e15754"}}